Today I’d like to share some practical insights drawn from working with numerous patients with endometriomas.

Here is one patient’s story. She is a business executive with a very busy schedule. We had previously offered her treatment recommendations, yet she thought her condition was straightforward and chose not to follow our advice. It was only after her treatment failed that she reached out to us again. Now she has successfully obtained three screened embryos and is preparing for embryo transfer.

Initially, she turned to a well‑established overseas fertility provider for an all‑in‑one service. Her plan was to have embryos cultured overseas and then transferred to Country G. Hoping for a hassle‑free and reliable experience, she placed her full trust in this provider. However, just three‑to‑four days after starting ovarian stimulation medication, the doctor decided to discontinue her cycle. The reason given was poor follicle growth and no response to medication, making further treatment unfeasible.
She was devastated. She had expected the process to be smooth, especially given she had nearly ten antral follicles. This unexpected failure hit her hard, prompting her to seek our consultation.

She is far from alone. We have had another patient who received treatment from a highly‑regarded top specialist in California, USA, without achieving satisfactory outcomes. Following our advice, she switched to our clinic and ultimately obtained screened blastocysts.

—————

Many people wonder:

Is treating endometrioma‑related infertility really so challenging? Why do so many top American specialists struggle with it?

I am not dismissing any hospitals or physicians’ professional competence. Every field has experts who excel in niche areas, and medicine is no exception. From our extensive clinical experience with these cases, endometrioma management demands exceptional, specialized hands‑on expertise.

Most doctors can handle routine fertility cases. But endometriomas are different!

Simply put, an endometrioma forms when endometrial tissue implants inside the ovary — the very organ where eggs develop and mature. The presence of an endometrioma creates a hostile internal ovarian environment. Eggs developing in this compromised setting suffer greatly in terms of drug responsiveness and quality.

This is the root cause behind many women with endometriomas experiencing poor ovarian stimulation response, stagnant follicle growth, repeated failed cycles yielding no high‑quality embryos, or even zero viable embryos after multiple stimulation attempts.

When a doctor lacks substantial real‑world experience treating endometriomas, they may struggle to fine‑tune medication protocols and adjustment timelines. The end result: patients endure injections, spend significant money, waste precious time, yet achieve nothing, leaving them emotionally devastated.

Therefore, the issue is not the treatment protocol itself nor the country of treatment; it hinges on a doctor’s specialized experience with endometrioma cases.

We collaborate with hundreds of clinics worldwide and have observed countless patient outcomes. We know which physicians excel at general fertility cases, which specialists focus on overcoming infertility caused by endometriomas, and which deliver outstanding results for advanced‑age patients.

One honest reality for women with endometriomas: endometriomas already pose major treatment hurdles, and the situation becomes even more difficult when combined with advanced maternal age.

Advanced age raises the risk of chromosomal abnormalities. For women aged 40‑45, the chance of chromosomally normal embryos is only around 20‑30%. On top of the poor ovarian environment caused by endometriomas, high chromosomal discard rates in older patients create a double‑edged challenge.

For illustration: suppose an older patient produces 10 retrieved eggs, of which 5 develop into blastocysts. With a 20‑30% rate of normal embryos, only 1‑2 viable embryos would be available for transfer. Yet few older women have as many as 10 baseline antral follicles. With a smaller follicle pool, success rates plummet — and endometrioma makes this situation even worse.

I advise everyone to prioritize regular health check‑ups and fertility assessments. If you are diagnosed with an endometrioma, do not select fertility services based on subjective assumptions, and do not oversimplify the treatment journey.

Choosing a physician with rich specialized experience in endometrioma‑related infertility is a critical step.

Wishing every woman success in her fertility journey. Feel free to share your own reproductive treatment experiences with us.